Skip to main navigation
Skip to search
Skip to main content
Help & FAQ
Search by expertise, name or affiliation
Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"
Ellen M. Mowry,
Contribution to journal
Dive into the research topics of 'Natalizumab wearing-off symptoms: Patients with MS on extended interval dosing may not "mind the gap"'. Together they form a unique fingerprint.